- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2859
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Production of glycoprotein vaccines in Escherichia coli ; volume:9 ; number:1 ; day:11 ; month:8 ; year:2010 ; pages:1-13 ; date:12.2010
Microbial cell factories ; 9, Heft 1 (11.8.2010), 1-13, 12.2010
- Creator
-
Ihssen, Julian
- Contributor
-
Kowarik, Michael
Dilettoso, Sandro
Tanner, Cyril
Wacker, Michael
Thöny-Meyer, Linda
SpringerLink (Online service)
- DOI
-
10.1186/1475-2859-9-61
- URN
-
urn:nbn:de:1111-2016072548681
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ihssen, Julian
- Kowarik, Michael
- Dilettoso, Sandro
- Tanner, Cyril
- Wacker, Michael
- Thöny-Meyer, Linda
- SpringerLink (Online service)
Other Objects (12)
Pyruvate production using engineered Escherichia coli
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Production of hydroxyproline with recombinant Escherichia coli
Microbubble assisted polyhydroxybutyrate production in Escherichia coli
Production of quinolone derivatives in Escherichia coli
Isobutanol production from cellobionic acid in Escherichia coli
Scalable production of biliverdin IXα by Escherichia coli
Isolating Escherichia coli strains for recombinant protein production
Ferulic acid production by metabolically engineered Escherichia coli
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Optimization of isopropanol production by engineered Escherichia coli
Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans
Pyruvate production using engineered Escherichia coli
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Production of hydroxyproline with recombinant Escherichia coli
Microbubble assisted polyhydroxybutyrate production in Escherichia coli
Production of quinolone derivatives in Escherichia coli
Isobutanol production from cellobionic acid in Escherichia coli
Scalable production of biliverdin IXα by Escherichia coli
Isolating Escherichia coli strains for recombinant protein production
Ferulic acid production by metabolically engineered Escherichia coli
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Optimization of isopropanol production by engineered Escherichia coli
Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans
Pyruvate production using engineered Escherichia coli
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Production of hydroxyproline with recombinant Escherichia coli
Microbubble assisted polyhydroxybutyrate production in Escherichia coli
Production of quinolone derivatives in Escherichia coli
Isobutanol production from cellobionic acid in Escherichia coli
Scalable production of biliverdin IXα by Escherichia coli
Isolating Escherichia coli strains for recombinant protein production
Ferulic acid production by metabolically engineered Escherichia coli
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Optimization of isopropanol production by engineered Escherichia coli